It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2008.
2008 | Chennai, Tamil Nadu, India | ActiveTranscend Therapeutics Private Limited, a active private limited company, was established on 04 June 2008 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230TN2008PTC068018. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Meena Chandrashekar (Director), Renuka Chandrasekaran (Director). Past directors included Renuka Chandrasekaran, Chandrashekar Ananthakrishnan. It holds ₹2.53 M open charges and ₹6.33 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat F, Ground Floor, No 1/600, Meenakshi Flats 5Th Street, Karthikeyapuram, Madipakkam, Chennai, Tamil Nadu, 600091.
U24230TN2008PTC068018
068018
04 June 2008
₹0.50 M
₹0.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Transcend Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meena Chandrashekar | Director | 01 Jun 2024 | Current |
| Renuka Chandrasekaran | Director | 04 Jun 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 01 Apr 2019 | Past |
| Pramod Abcsdd | Whole-Time Director | 01 Apr 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Transcend Therapeutics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 27.88% increase. The company also saw a substantial improvement in profitability, with a 198.71% increase in profit. The company's net worth Soared by an impressive increase of 21.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Transcend Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,525,000.00
₹6,325,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jul 2023 | Others | ₹1.23 M | Satisfied |
| 20 May 2023 | Others | ₹1.30 M | Satisfied |
| 28 Jun 2017 | Others | ₹3.80 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Transcend Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Transcend Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transcend Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 03 Jul 2023 via Charge ID 100748488 with Others was fully satisfied on 19 Nov 2025. was completed.
Progress on A charge registered on 20 May 2023 via Charge ID 100727096 with Others was fully satisfied on 19 Nov 2025. was documented.
Transcend Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Transcend Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was recorded as a recent event.
The activity Meena Chandrashekar was appointed as a Director was appointed as a Director on 01 Jun 2024 & has been associated with this company since 1 year 6 months . was completed.
A charge with Others amounted to Rs. 1.23 M with Charge ID 100748488 was registered on 03 Jul 2023. was recorded as a recent event.
The CIN of Transcend Therapeutics Private Limited is U24230TN2008PTC068018.
Transcend Therapeutics Private Limited is headquartered at Flat F, Ground Floor, No 1/600, Meenakshi Flats 5Th Street, Karthikeyapuram, Madipakkam, Chennai, Tamil Nadu, 600091.
Transcend Therapeutics Private Limited was incorporated on 04 June 2008.
The current directors of Transcend Therapeutics Private Limited are
The primary industry of Transcend Therapeutics Private Limited is Trade.
Transcend Therapeutics Private Limited is unlisted.
The authorized capital of Transcend Therapeutics Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Transcend Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX